Morocco

Societe De Therapeutique Marocaine Sa (الشركة المغربية للعلاج)

An EMIS Company Report EMIS is a Euromoney Institutional Investor plc company USD 29.95 Industry: Pharmaceutical and Medicine Manufacturing Available in: English & Arabic Format: PDF Download Buy full report

What’s included?

This report extracts all available information about Societe De Therapeutique Marocaine Sa from EMIS' database of company information. The Table of Contents on the right indicates the categories of information that will be included in your report upon purchase.

Download a sample report

Company Tear Sheet (locked content will be provided in the purchased report)

Contact Information

Legal Address
Centre De Bouskoura , Bp N°1
Casablanca; Casablanca - Settat; Map

Tel: +212-052232
Fax: +212-052233

Email:
@sothema.ma

Website:
http://www.sothema.com

Company Description
Sothema SA is a Morocco-based company specialized in the production and marketing of drugs, created on 26/01/1976 and the IPO dated on 21/02/2005. The Company provides drugs in the forms of tablets, capsules, syrups, ampoules, creams and ointments, as well as powders and suspensions for injections, among others. It exports the substantial share of its output to Europe, North and sub-Saharan Africa, among others, and it is also engaged in the manufacture of drugs under license and the importation of dental products. Sothema SA operates a subsidiary, West Afric Pharma, based in Senegal.
NAICS Industry Classification
Main Activities: Pharmaceutical and Medicine Manufacturing
Basic Information
Total Employees:
443 (2012)
Outstanding Shares:
: ()
Registered Capital:
()
Financial Auditors:
()
Incorporation Date:
1976
Profile Updated:
January 07, 2018
Key Executives
Executive Vice President
Chairperson
Director / Member of the Management Board
Director / Member of the Management Board
Director / Member of the Management Board
More
Ownership Details
Omar Tazi
31.99%
More
Key Financial Highlights
2017 Q2C
Net sales revenue
Total operating revenue
Operating profit (EBIT)
EBITDA
Net Profit (Loss) for the Period
Total assets 1,172,079
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Audited, Consolidated
Source: World's Vest Base, EMIS Company Database.
Financial Performance Charts

EMIS Credit Analytics

EMIS Benchmark Score

Latest News (Not included in the report)

Enterprise ACCESS

If you need regular and ongoing access to company information, you should consider a subscription to the full EMIS service.

EMIS company profiles are part of a larger information service where that combines company, industry and country data and analysis for over 125 emerging markets on a unique information platform.

REQUEST A DEMO

To view more information, REQUEST A DEMO